The Role of VP of Quality in Pharma Regulatory Compliance

Journey of Lisa, a VP of quality at a pharma company. Here's how she handles highly volatile situations calmly, continues her work & ensures high quality.

## How a VP of Quality connects product quality, compliance, suppliers, and continuous improvement Lisa is the VP of Quality at a pharmaceutical company. Her responsibility extends across Quality Assurance, Quality Control, compliance, suppliers, third-party manufacturers, and the quality aspects of product commercialization. Her role is ultimately about protecting the quality of the product while ensuring the organization operates within its quality and regulatory requirements. That means balancing two demands every day: maintaining control over what is happening now while building a quality system that helps the organization improve what happens next. ## The Challenge ### Quality responsibility spans the entire operation. Lisa doesn't manage quality as an isolated department. She provides strategic direction for QA, QC, and compliance. She oversees supplier quality, audits, quality agreements, and relationships. She supports third-party manufacturing processes and the quality requirements surrounding product commercialization. At the same time, the organization expects quality to contribute to broader business objectives: improving product standards, protecting brand reputation, reducing unnecessary risk, and driving continuous improvement. The challenge is that those responsibilities depend on information spread across products, batches, inventory, suppliers, approvals, quality records, and compliance activities. When that information is difficult to trace or analyze, Lisa's team spends more time reconstructing what happened and less time improving what happens next. ## The Approach ### Build the quality operation around traceability, control, and insight. Lisa needs more than a place to store quality records. She needs a quality environment capable of connecting the evidence behind a product and batch—from QA and QC records through approvals, traceability, compliance reporting, and supplier oversight. The required foundation includes cGMP and 21 CFR Part 11 compliance, lot inheritance and batch traceability, electronic signatures on key transactions, audit and compliance reporting, and accessible QA and QC records. The journey centers on six areas where those capabilities directly support Lisa's responsibilities. ### 01. Product Quality **Maintain control over the quality of every product.** Lisa's first responsibility is the quality of the pharmaceutical products the organization manufactures. She provides strategic direction across QA, QC, and compliance while overseeing quality considerations associated with product commercialization. Her objective is not simply to identify failures. She needs quality standards and processes that help protect product performance and the reputation of the organization. **Journey impact:** Product quality becomes part of a coordinated quality strategy rather than a collection of individual inspections and records. ### 02. Batch Traceability **Answer the question: What happened to this batch?** One of Lisa's biggest operational frustrations is the inability to perform an immediate electronic batch trace. When an issue arises, the quality team needs to follow the history of the batch without manually reconstructing information from disconnected records. Lot inheritance and electronic batch traceability provide a clearer path through that history—supporting inventory traceability as well as the information needed during quality and compliance activities. **Journey impact:** Lisa's team can move toward tracing the history of a batch through connected electronic records rather than reconstructing it manually. ### 03. Review & Approval **Know who reviewed what—and who approved it.** Traceability isn't only about the product. Lisa also needs confidence in the decisions surrounding it. The existing process makes it difficult to determine whether paperwork has been attested by the appropriate approvers. For a regulated quality process, that creates additional work whenever the organization needs to establish who reviewed or approved a critical transaction. Electronic signatures on key transactions create a stronger connection between the quality record, the decision, and the person responsible for it. **Journey impact:** Critical quality decisions have a clearer electronic record of review and approval. ### 04. Compliance & Audit Readiness **Make evidence easier to find before the audit begins.** Cumbersome reporting makes FDA audits more difficult than they need to be. Lisa needs to track compliance across product storage, manufacturing, and quality activities while maintaining the records needed to demonstrate that control. Audit reporting, compliance reporting, electronic signatures, and traceable QA and QC records provide the foundation for making that information easier to retrieve and review. **Journey impact:** Audit preparation shifts from reconstructing evidence toward working from more structured and accessible compliance records. ### 05. Supplier & Third-Party Quality **Extend quality oversight beyond the four walls of the organization.** Lisa's responsibility doesn't stop with internally manufactured products. She also oversees supplier quality and compliance, audits, quality agreements, relationship management, and processes supporting third-party manufacturers. That means supplier and external manufacturing quality need to fit within the same overall quality strategy as internal operations. **Journey impact:** Supplier and third-party quality become part of the organization's broader approach to quality oversight and compliance. ### 06. Continuous Improvement **Use today's quality information to improve tomorrow's process.** Lisa doesn't only need to understand individual quality events. She needs to understand whether they form a pattern. One of the existing pain points is the inability to identify trends that could help the organization improve processes proactively. Without effective trending and analysis, valuable quality information can remain trapped in individual records. Connecting QA, QC, product, batch, supplier, and compliance information creates a stronger foundation for identifying recurring issues and directing continuous-improvement efforts. **Journey impact:** Quality information becomes an input to improvement—not simply a historical record of what happened. ## Who Benefits ### Better quality information supports decisions across the organization. Although Lisa owns the quality strategy, the impact extends beyond the VP of Quality.

## The Outcome ### From managing quality records to leading a connected quality operation. Lisa's journey begins with a demanding responsibility: protect product quality while maintaining compliance across an increasingly interconnected pharmaceutical operation. The challenge isn't a lack of quality activity. It's making sure that the records, batches, approvals, suppliers, compliance evidence, and quality information behind those activities remain connected and usable. The journey moves the organization from: - **Manual batch investigation → Electronic batch traceability** - **Difficult-to-verify paperwork → Traceable electronic approvals** - **Cumbersome audit preparation → More accessible compliance evidence** - **Separate supplier activities → Connected supplier quality oversight** - **Individual quality records → Better trending and analysis** - **Reactive quality management → Continuous improvement** The result is a quality environment designed to help Lisa answer three critical questions: **What happened?**\ Trace the product, lot, batch, quality records, and supporting activity. **Was it properly controlled?**\ Review approvals, signatures, QA/QC records, and compliance evidence. **What should we improve next?**\ Use quality information and patterns to direct continuous-improvement efforts. For a VP of Quality, that's the bigger transformation: moving from managing individual quality activities to having a more connected view of the quality operation she is responsible for.

Ready to improve batch traceability, quality approvals, and compliance? Let's talk about your pharmaceutical quality challenges.